Differential expression of TIM-3 between primary and metastatic sites in renal cell carcinomaXingming Zhang, Hao Zeng|BMC Cancer|2019Cited by 25
Neuroendocrine differentiation predicts the therapeutic efficacy of abiraterone and docetaxel as first-line therapy in metastatic castration-resistant prostate cancerNanwei Xu, Hao Zeng|Journal of Cancer Research and Clinical Oncology|2023Cited by 6
Efficacy of Second-Line ICIs Combined with TKIs among Patients with Metastatic Renal Cell Carcinoma: A Real-World StudyHaoran Zhang, Pengfei Shen, Xingming Zhang et al.|Immunotherapy|2022Cited by 2